BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2018 11:38:21 AM | Browse: 503 | Download: 701
Publication Name World Journal of Gastroenterology
Manuscript ID 41334
Country/Territory Taiwan
2018-08-07 01:31
Peer-Review Started
2018-08-07 06:07
To Make the First Decision
2018-08-27 01:56
Return for Revision
2018-08-27 06:28
2018-09-20 10:59
Second Decision
2018-09-27 06:18
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-10-05 23:04
Articles in Press
2018-10-05 23:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-10-15 05:26
Publish the Manuscript Online
2018-10-26 11:38
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Second-line rescue treatment of Helicobacter pylori infection: Where are we now?
Manuscript Source Invited Manuscript
All Author List Te-Fu Lin and Ping-I Hsu
Author(s) ORCID Number
Te-Fu Lin http://orcid.org/0000-0003-1996-5008
Ping-I Hsu http://orcid.org/0000-0003-3905-4674
Funding Agency and Grant Number
Corresponding Author Ping-I Hsu, MD, Attending Doctor, Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, 386 Ta Chung 1st Road, Kaohsiung 813, Taiwan. williamhsup@yahoo.com.tw
Key Words Helicobacter pylori; Rescue treatment; Levofloxacin-amoxicillin triple therapy; Bismuth quadruple therapy; Tetracycline-levofloxacin quadruple therapy; High-dose dual therapy
Core Tip The present article reviews current second-line anti-Helicobacter pylori (H. pylori) regimens. Bismuth quadruple therapy and levofloxacin-amoxicillin triple therapy have comparable eradication rates in the rescue treatment of H. pylori infection, while the former has more adverse effects than the latter. High-dose dual therapy has an eradication rate comparable with levofloxacin-amoxicillin triple therapy. Ten-day tetracycline-levofloxacin quadruple therapy achieves a markedly higher eradication rate compared with levofloxacin-amoxicillin triple therapy (98% vs 69%) in patients with failure of standard triple, bismuth quadruple or non-bismuth quadruple therapy. In conclusion, tetracycline-levofloxacin quadruple therapy has the potential to become a universal second-line treatment for H. pylori infection.
Publish Date 2018-10-26 11:38
Citation Lin TF, Hsu PI. Second-line rescue treatment of Helicobacter pylori infection: Where are we now? World J Gastroenterol 2018; 24(40): 4548-4553
URL http://www.wjgnet.com/1007-9327/full/v24/i40/4548.htm
DOI http://dx.doi.org/10.3748/wjg.v24.i40.4548
Full Article (PDF) WJG-24-4548.pdf
Full Article (Word) WJG-24-4548.doc
Manuscript File 41334-Review.docx
Answering Reviewers 41334-Answering reviewers.pdf
Audio Core Tip 41334-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 41334-Conflict-of-interest statement.pdf
Copyright License Agreement 41334-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 41334-Language certificate.pdf
Supplementary Material 41334-Supplementary-Material-revision.docx
Peer-review Report 41334-Peer-review(s).pdf
Scientific Misconduct Check 41334-Scientific misconduct check.pdf
Scientific Editor Work List 41334-Scientific editor work list.pdf